ART Trial: Transcatheter J-VALVE Versus Surgery for Aortic Regurgitation Therapy

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1250 participants.

Also called NCT07453407

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 1,250 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07453407
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07453407. Randomized; single masking; primary purpose treatment. Start 2026-03-05 (actual); primary completion 2029-03 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
ART Trial: Transcatheter J-VALVE Versus Surgery for Aortic Regurgitation Therapy
Acronym
ART
Condition
Aortic Regurgitation
Condition
Aortic Valve Insufficiency
Condition
Aortic Insufficiency
Intervention (Device)
J-VALVE Transfemoral Aortic Valve system
Intervention (Device)
Commercially available surgical biological aortic valve replacement device
Lead sponsor
Second Affiliated Hospital, Zhejiang University, School of Medicine (class: other)

Record details

Record id
cardio:ct-nct07453407
Content hash
b193a2fb5bb577f4d09a1b6c245202a4169b4355db31028d1d6e810e74e570a8